Sagimet Biosciences Inc. Series A Common Stock
SGMT
$8.93+0.11%
End of day · as of Oct 10, 2026, 2:02 AM ET
Mkt cap
$403.24M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2023-09-30)
$2.00M
EPS (H1 2026)
$-0.57
Gross Margin (qtr ended 2023-09-30)
N/A
Profit Margin (qtr ended 2023-09-30)
-317.65%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
Use this SGMT research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full SGMT income, balance, and cash tables.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company in the Healthcare sector.
Latest cached Sagimet Biosciences Inc. Series A Common Stock (SGMT) revenue for Sep 30, 2023 was $2.0M. Net income was -$6.4M. Statements: https://lician.com/financials/sgmt
Sagimet Biosciences Inc. Series A Common Stock (SGMT) market capitalization is $403.2M on the latest cached snapshot.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) cached previous close $8.92; day range $8.78 – $9.05; volume 763,394. Session quote: https://lician.com/quote/sgmt
Sagimet Biosciences Inc. Series A Common Stock (SGMT) latest cached earnings event is "SGMT earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached SGMT filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/sgmt